A case of coronavirus reinfection shows the complexities of the pandemic
Companies, agencies, institutions, etc
The Boston
Stat News
testThe Food and Drug Administration
Verge)Moderna
the First Coronavirus Vaccines
Pfizer
COVID-19
the Center for Vaccines and Immunology
the University of Georgia
The New York Times
the Life Care
UNC
People
Jonathan Saltzman
Helen Branswell
Abbott
Nicole Wetsman
Peter Loftus
Ted Ross
Carl Zimmer
Katie Engelhart
Chelsey Earnest
COVID
Brandon Standley
Nadworny
Lauren Migaki
Groups
COVID-19
Physical locations
Europe
Places
the Life Care Center
Locations
Nevada
Hong Kong
Boston
US
Best?While
The New York
Kirkland
Washington
the United States
Engelhart
California
Events
No matching tags
Summary
Filed under:Antivirus: A weekly digest of the latest COVID-19 researchThe scary thing finally happened: someone caught the coronavirus twice and got sicker the second time around. In these reinfection cases, though, researchers actually analyzed the virus from the first time the people got sick and compared it to the virus from the second time they got sick. The other possibility is that he had antibodies, but they made the infection worse (it happens with other viruses, like dengue). Most researchers think people will have some protection against the virus, but they still don’t know what that protection will look like. (Nicole Wetsman / The Verge)Moderna Says Covid-19 Vaccine Shows Signs of Working in Older AdultsThe drug company ran a small study testing their COVID-19 vaccine candidate in people over the age of 56, and it found they produced the same types of immune response that younger people did.
As said here by Nicole Wetsman